ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-pxvi.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-pxvi.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-pxxv.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-pxxv.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1311.xmlA US Registry–Based Assessment of Use and Impact of Chemotherapy in Stage I HER2-Positive Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1311.pdf2026-04-18A US Registry–Based Assessment of Use and Impact of Chemotherapy in Stage I HER2-Positive Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1289.xmlNCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.20182026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1289.pdf2026-04-18NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018https://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1279.xmlThe Adrenal Gland as a Sanctuary Site of Metastases After Pembrolizumab Treatment: A Case Series2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1279.pdf2026-04-18The Adrenal Gland as a Sanctuary Site of Metastases After Pembrolizumab Treatment: A Case Serieshttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1273.xmlI'm Conflicted. Are You?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1273.pdf2026-04-18I'm Conflicted. Are You?https://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1340.xmlEvaluation of New Tests and Interventions for Prostate Cancer Management: A Systematic Review2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1340.pdf2026-04-18Evaluation of New Tests and Interventions for Prostate Cancer Management: A Systematic Reviewhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1321.xmlImpact of a Clinical Decision Support System on Guideline Adherence of Surveillance Recommendations for Colonoscopy After Polypectomy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1321.pdf2026-04-18Impact of a Clinical Decision Support System on Guideline Adherence of Surveillance Recommendations for Colonoscopy After Polypectomyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1353.xmlUndertreatment of High-Risk Localized Prostate Cancer in the California Latino Population2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1353.pdf2026-04-18Undertreatment of High-Risk Localized Prostate Cancer in the California Latino Populationhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1362.xmlBreast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1362.pdf2026-04-18Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncologyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1398.xmlScreening Mammography for Average-Risk Women: The Controversy and NCCN's Position2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1398.pdf2026-04-18Screening Mammography for Average-Risk Women: The Controversy and NCCN's Positionhttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1391.xmlDiagnosis and Management of High-Risk Breast Lesions2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1391.pdf2026-04-18Diagnosis and Management of High-Risk Breast Lesionshttps://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1406.xmlElectronic Clinical Decision Tools for Improving Adherence to Colon Cancer Surveillance Guidelines: Can the Chips Finally Fall Into Place?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/16/11/article-p1406.pdf2026-04-18Electronic Clinical Decision Tools for Improving Adherence to Colon Cancer Surveillance Guidelines: Can the Chips Finally Fall Into Place?https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p1.xmlLetter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studies2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p1.pdf2026-04-18Letter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studieshttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p9.xmlCancer in People Living With HIV, Version 1.20182026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p9.pdf2026-04-18Cancer in People Living With HIV, Version 1.2018https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p3.xmlAuthor’s Reply to Letter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studies2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p3.pdf2026-04-18Author’s Reply to Letter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studieshttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p25.xmlChimeric Antigen Receptor (CAR) T-Cell Therapy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p25.pdf2026-04-18Chimeric Antigen Receptor (CAR) T-Cell Therapyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p19.xmlNCCN Convenes Summit on Providing High-Quality Cancer Care in an Evolving Policy and Tech Landscape2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p19.pdf2026-04-18NCCN Convenes Summit on Providing High-Quality Cancer Care in an Evolving Policy and Tech Landscapehttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p5.xmlNotes From the Other Side2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p5.pdf2026-04-18Notes From the Other Sidehttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p66.xmlDNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p66.pdf2026-04-18DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p51.xmlColorectal Cancer Screening, Version 1.20182026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p51.pdf2026-04-18Colorectal Cancer Screening, Version 1.2018https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p41.xmlEvaluating Antiretroviral Therapy Initiation in HIV-Associated Malignancy: Is There Enough Evidence to Inform Clinical Guidelines?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p41.pdf2026-04-18Evaluating Antiretroviral Therapy Initiation in HIV-Associated Malignancy: Is There Enough Evidence to Inform Clinical Guidelines?https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p46.xmlDoes Chemoradiation Benefit Patients With Gastric Cancer Managed Without Surgery?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p46.pdf2026-04-18Does Chemoradiation Benefit Patients With Gastric Cancer Managed Without Surgery?https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p87.xmlEvolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p87.pdf2026-04-18Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trialshttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p75.xmlChemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p75.pdf2026-04-18Chemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p31.xmlRedefining Quality Measurement in Cancer Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/1/article-p31.pdf2026-04-18Redefining Quality Measurement in Cancer Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p9.xmlCancer in People Living With HIV, Version 1.20182026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p9.pdf2026-04-18Cancer in People Living With HIV, Version 1.2018https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p5.xmlNotes From the Other Side2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p5.pdf2026-04-18Notes From the Other Sidehttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p3.xmlAuthor’s Reply to Letter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studies2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p3.pdf2026-04-18Author’s Reply to Letter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studieshttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p1.xmlLetter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studies2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p1.pdf2026-04-18Letter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studieshttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p25.xmlChimeric Antigen Receptor (CAR) T-Cell Therapy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p25.pdf2026-04-18Chimeric Antigen Receptor (CAR) T-Cell Therapyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p31.xmlRedefining Quality Measurement in Cancer Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p31.pdf2026-04-18Redefining Quality Measurement in Cancer Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p19.xmlNCCN Convenes Summit on Providing High-Quality Cancer Care in an Evolving Policy and Tech Landscape2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p19.pdf2026-04-18NCCN Convenes Summit on Providing High-Quality Cancer Care in an Evolving Policy and Tech Landscapehttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p51.xmlColorectal Cancer Screening, Version 1.20182026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p51.pdf2026-04-18Colorectal Cancer Screening, Version 1.2018https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p41.xmlEvaluating Antiretroviral Therapy Initiation in HIV-Associated Malignancy: Is There Enough Evidence to Inform Clinical Guidelines?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p41.pdf2026-04-18Evaluating Antiretroviral Therapy Initiation in HIV-Associated Malignancy: Is There Enough Evidence to Inform Clinical Guidelines?https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p66.xmlDNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p66.pdf2026-04-18DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p46.xmlDoes Chemoradiation Benefit Patients With Gastric Cancer Managed Without Surgery?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p46.pdf2026-04-18Does Chemoradiation Benefit Patients With Gastric Cancer Managed Without Surgery?https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p75.xmlChemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p75.pdf2026-04-18Chemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p87.xmlEvolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2018/2/article-p87.pdf2026-04-18Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trialshttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p3.xmlAuthor’s Reply to Letter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studies2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p3.pdf2026-04-18Author’s Reply to Letter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studieshttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p1.xmlLetter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studies2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p1.pdf2026-04-18Letter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studieshttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p5.xmlNotes From the Other Side2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p5.pdf2026-04-18Notes From the Other Sidehttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p31.xmlRedefining Quality Measurement in Cancer Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p31.pdf2026-04-18Redefining Quality Measurement in Cancer Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p9.xmlCancer in People Living With HIV, Version 1.20182026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p9.pdf2026-04-18Cancer in People Living With HIV, Version 1.2018https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p25.xmlChimeric Antigen Receptor (CAR) T-Cell Therapy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p25.pdf2026-04-18Chimeric Antigen Receptor (CAR) T-Cell Therapyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p19.xmlNCCN Convenes Summit on Providing High-Quality Cancer Care in an Evolving Policy and Tech Landscape2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p19.pdf2026-04-18NCCN Convenes Summit on Providing High-Quality Cancer Care in an Evolving Policy and Tech Landscapehttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p41.xmlEvaluating Antiretroviral Therapy Initiation in HIV-Associated Malignancy: Is There Enough Evidence to Inform Clinical Guidelines?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p41.pdf2026-04-18Evaluating Antiretroviral Therapy Initiation in HIV-Associated Malignancy: Is There Enough Evidence to Inform Clinical Guidelines?https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p46.xmlDoes Chemoradiation Benefit Patients With Gastric Cancer Managed Without Surgery?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p46.pdf2026-04-18Does Chemoradiation Benefit Patients With Gastric Cancer Managed Without Surgery?https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p66.xmlDNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p66.pdf2026-04-18DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p51.xmlColorectal Cancer Screening, Version 1.20182026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p51.pdf2026-04-18Colorectal Cancer Screening, Version 1.2018https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p87.xmlEvolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p87.pdf2026-04-18Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trialshttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p75.xmlChemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/1/article-p75.pdf2026-04-18Chemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p3.xmlAuthor’s Reply to Letter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studies2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p3.pdf2026-04-18Author’s Reply to Letter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studieshttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p1.xmlLetter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studies2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p1.pdf2026-04-18Letter to the Editor: Integrating Skeletal Muscle Mass and Radiodensity Improves Outcome Prediction and Correlation in Oncologic Studieshttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p9.xmlCancer in People Living With HIV, Version 1.20182026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p9.pdf2026-04-18Cancer in People Living With HIV, Version 1.2018https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p25.xmlChimeric Antigen Receptor (CAR) T-Cell Therapy2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p25.pdf2026-04-18Chimeric Antigen Receptor (CAR) T-Cell Therapyhttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p19.xmlNCCN Convenes Summit on Providing High-Quality Cancer Care in an Evolving Policy and Tech Landscape2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p19.pdf2026-04-18NCCN Convenes Summit on Providing High-Quality Cancer Care in an Evolving Policy and Tech Landscapehttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p5.xmlNotes From the Other Side2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p5.pdf2026-04-18Notes From the Other Sidehttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p31.xmlRedefining Quality Measurement in Cancer Care2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p31.pdf2026-04-18Redefining Quality Measurement in Cancer Carehttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p66.xmlDNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p66.pdf2026-04-18DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p51.xmlColorectal Cancer Screening, Version 1.20182026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p51.pdf2026-04-18Colorectal Cancer Screening, Version 1.2018https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p41.xmlEvaluating Antiretroviral Therapy Initiation in HIV-Associated Malignancy: Is There Enough Evidence to Inform Clinical Guidelines?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p41.pdf2026-04-18Evaluating Antiretroviral Therapy Initiation in HIV-Associated Malignancy: Is There Enough Evidence to Inform Clinical Guidelines?https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p46.xmlDoes Chemoradiation Benefit Patients With Gastric Cancer Managed Without Surgery?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p46.pdf2026-04-18Does Chemoradiation Benefit Patients With Gastric Cancer Managed Without Surgery?https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p87.xmlEvolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p87.pdf2026-04-18Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trialshttps://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p75.xmlChemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/2019/2/article-p75.pdf2026-04-18Chemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancer